Company lists · Data refreshed September 2026
Top 17 Drug discovery venture capital companies based in France
RevenueBase identified 37 drug discovery venture capital companies headquartered in France as of September 2026 and tracks 657 professional contacts across them, including 222 with verified work emails and 19 with mobile numbers. Paris is the largest hub.
This list covers drug discovery venture capital companies headquartered in France, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 1, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 17 largest drug discovery venture capital companies based in France
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 351 contacts → | ||||
Strong evidence “Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 2 | 41 contacts → | ||||
Indirect evidence “Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the…” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 3 | 40 contacts → | ||||
Indirect evidence “Jeito is a next-generation fund with a patient benefit driven approach, that focuses both on financing ground-breaking medical innovation and promoting positive societal impact.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 4 | 28 contacts → | ||||
Strong evidence “Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on…” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 5 | 24 contacts → | ||||
Strong evidence “Angelor is a venture capital company based out of 22 RUE SEGUIN, Lyon, Rhne-Alpes, France.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 6 | 24 contacts → | ||||
Indirect evidence “Le Centre d’Etudes et de Recherche sur le Médicament de Normandie · CERMN · constitue aujourd’hui, avec ses quatre plateformes · Chimie Organique et Médicinale, Chemoinformatique…” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 7 | 15 contacts → | ||||
Indirect evidence “Argobio Studio is the launch platform for Europe’s best medicinal science.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 8 | 10 contacts → | ||||
Strong evidence “AdBio Partners is a venture capital firm dedicated to transforming breakthrough science into patient-ready therapies.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 9 | 10 contacts → | ||||
Strong evidence “Meddenovo is advancing AI-driven drug discovery with a specialized technology platform designed specifically for cyclic peptides.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 10 | 7 contacts → | ||||
Strong evidence “BCI Pharma is an innovative bio-pharmaceutical company focused on small molecule drug discovery.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 11 | 6 contacts → | ||||
Indirect evidence “At MedInsights, we are dedicated to bringing optimized therapeutic options for patients suffering from metabolic, cardiometabolic, neurometabolic and rare diseases with high unmet…” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 12 | 4 contacts → | ||||
Partial evidence “Ampleia is a venture-building organization dedicated to support rare diseases therapeutics projects.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 13 | 4 contacts → | ||||
Indirect evidence “VC firm investing in European growth stage digital health companies.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 14 | 3 contacts → | ||||
Indirect evidence “Investing in early stage healthcare startups” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 15 | 3 contacts → | ||||
Strong evidence “Headquartered in Paris and London, Óskare Capital specializes in venture-stage investments in the Deeptech and Life Sciences sectors.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 16 | 1 contacts → | ||||
Indirect evidence “Our name comes from the startup studio concept which we want to roll out in the Biotech world.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
| 17 | 1 contacts → | ||||
Indirect evidence “We offer a unique solution for creating innovative healthcare startups, often built on the foundations of academic research programs.” Source: RevenueBase Database · checked Sep 1, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: drug discovery venture capital companies. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names drug discovery venture capital companies.
- Partial evidence
- Its own public description names part of drug discovery venture capital companies, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name drug discovery venture capital companies. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 17 of 37 drug discovery venture capital companies based in France
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 222 reachable decision-makers.
Free signup · no credit card
Drug discovery venture capital companies based in France at a glance
As of Sep 1, 2026Companies by employee count
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among drug discovery venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in France whose own description of what they do matches “drug discovery venture capital companies”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names drug discovery venture capital companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among drug discovery venture capital companies, and records with no verified work email. Companies headquartered outside France are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 222 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 1, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names drug discovery venture capital companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many drug discovery venture capital companies are there based in France?
RevenueBase identified 37 drug discovery venture capital companies headquartered in France as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Novalix, headquartered in Strasbourg, tops this list with the largest team on record.
Which city has the most drug discovery venture capital companies?
Paris leads with 12 headquartered companies, followed by Lyon (3) and Montpellier (3).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 222 verified decision-maker contacts tracked across these 37 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 1, 2026.
Ready to reach these companies? Verified emails and direct dials for all 37 drug discovery venture capital companies based in France. Start with a free account, no credit card.
Download this list →Related lists
Drug discovery venture capital companies by geography
- Drug discovery venture capital companies based in the United States
- Drug discovery venture capital companies based in the United Kingdom
- Drug discovery venture capital companies based in Canada
- Drug discovery venture capital companies based in Germany
- Drug discovery venture capital companies based in Switzerland
- Drug discovery venture capital companies based in Spain
- Drug discovery venture capital companies based in Israel
- Drug discovery venture capital companies based in Australia
- Drug discovery venture capital companies based in Italy
- Drug discovery venture capital companies based in London, United Kingdom
- Drug discovery venture capital companies based in Boston, United States
- Drug discovery venture capital companies based in Cambridge, United States
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Drug discovery venture capital companies based in the United States
- Drug discovery venture capital companies based in the United Kingdom
- Drug discovery venture capital companies based in Canada
- Drug discovery venture capital companies based in Germany
- Drug discovery venture capital companies based in Switzerland
- Drug discovery venture capital companies based in Spain